Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors.

Literature DB >> 20484875

ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors.

Beata Kos-Kudła¹, Dermot O'Toole, Massimo Falconi, David Gross, Günther Klöppel, Anders Sundin, John Ramage, Kjell Oberg, Bertram Wiedenmann, Paul Komminoth, Eric Van Custem, Mohandes Mallath, Mauro Papotti, Martyn Caplin.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20484875 DOI： 10.1159/000287255

Source DB: PubMed Journal: Neuroendocrinology ISSN： 0028-3835 Impact factor: 4.914

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

Review 1. [Metastatic neuroendocrine neoplasms. Non-surgical treatment strategies].

Authors: M Pavel
Journal: Chirurg Date: 2011-07 Impact factor: 0.955

2. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.

Authors: Krystallenia I Alexandraki; Michail Pizanias; Inbal Uri; Dimitrios Thomas; Tristan Page; Denise Kolomodi; Chen Sheng Low; Olu Adesanya; Marina Tsoli; David J Gross; Harpal Randeva; Rajaventhan Srirajaskanthan; Simona Grozinsky-Glasberg; Gregory Kaltsas; Martin O Weickert
Journal: Endocrine Date: 2019-01-11 Impact factor: 3.633

3. Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors: Stephan Petersenn; Christian A Koch
Journal: Rev Endocr Metab Disord Date: 2017-12 Impact factor: 6.514

Review 4. [Neuroendocrine colorectal tumors. Surgical and endoscopic treatment].

Authors: H G Hotz; C Bojarski; H J Buhr
Journal: Chirurg Date: 2011-07 Impact factor: 0.955

5. May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotate.

Authors: Amir Sabet; Feras Khalaf; Soha Mahjoob; Abdullah Al-Zreiqat; Hans-Jürgen Biersack; Samer Ezziddin
Journal: Am J Nucl Med Mol Imaging Date: 2013-12-15

ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors.

Review 1. [Metastatic neuroendocrine neoplasms. Non-surgical treatment strategies].

2. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.

3. Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Review 4. [Neuroendocrine colorectal tumors. Surgical and endoscopic treatment].

5. May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotate.

Review 6. Therapy for metastatic pancreatic neuroendocrine tumors.

7. Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.

Review 8. Management of pulmonary neuroendocrine tumors.

Review 9. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.

10. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.